Aim Stroke is the leading cause of disability and death in China. Ischaemic stroke accounts
for about 60%–80% of all strokes. It is of considerable significance to carry out …

Cerebral venous thrombosis (CVT) is an important cause of stroke in young adults. Data
from large international registries published in the past two decades have greatly improved …

Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …

Background: As of 8 April 2021, a total of 2.9 million people have died with or from the
coronavirus infection causing COVID-19 (Corona Virus Disease 2019). On 29 January 2021 …

Background and purpose Population‐based studies suggest that severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) vaccines may trigger immune‐mediated thrombotic …

The current proposal for cerebral venous thrombosis guideline followed the Grading of
Recommendations, Assessment, Development, and Evaluation system, formulating relevant …

Recent reports have highlighted rare, and sometimes fatal, cases of cerebral venous sinus
thrombosis (CVST) and thrombocytopenia following the Vaxzevria vaccine. An underlying …

Importance Patients with cerebral venous thrombosis (CVT) are at risk of recurrent venous
thrombotic events (VTEs). Non–vitamin K oral anticoagulants have not been evaluated in …

Purpose—The aim of this statement is to summarize data on stroke risk factors that are
unique to and more common in women than men and to expand on the data provided in …

Background A new syndrome of vaccine-induced immune thrombotic thrombocytopenia
(VITT) has emerged as a rare side-effect of vaccination against COVID-19. Cerebral venous …